CVS Well being companions with ixlayer for branded dwelling testing kits

Digital diagnostics firm ixlayer has introduced that it’ll produce the CVS Well being-branded dwelling specimen assortment kits.

Ixlayer’s kits can check for Lyme illness, vitamin D ranges, thyroid operate, and sexually transmitted infections. Customers additionally obtain coaching and data on the which means of the outcomes.

Customers can now buy CVS Well being branded assessments on-line or decide up a check in-store at choose CVS areas.

As soon as bought, the tester prompts his account and sends his pattern in a pay as you go courier. By ixlayer, check outcomes are supplied to customers by way of a web-based portal.

“With close to 70% of medical selections depending on laboratory testing, common diagnostic testing is the cornerstone of enhancing well being and well-being,” stated Pouria Sanae, CEO and co-founder of ixlayer, in an announcement. “Residence testing permits folks to proactively take management of their well being, on their very own. hourly, within the privateness of their very own dwelling and regularly.”


The house testing market has grown and traders have taken discover.

Morgan Well beingJP Morgan Chase’s healthcare enterprise unit, introduced a $20 million strategic funding in LetsGetChecked, an organization offering dwelling testing for sexual well being, diabetes, fertility hormones, ldl cholesterol and blood sugar. COVID-19.

LetsGetChecked closed a Sequence D funding spherical of $150 million in 2021, constructing on will increase in 2018, 2019 and 2020.

In April, the diagnostics large Labcorp in partnership with Getlabs to supply dwelling pattern assortment for laboratory testing.

The service, Getlabs for Labcorp, permits customers to ebook an appointment on-line for a house blood draw. A phlebotomist can take saliva, stool, urine, and breath samples, and measure very important indicators. Assortment prices a comfort price beginning at $25.

Based mostly in Florida Getlabswhich additionally gives samples for Quest Diagnostics, secured $20 million in Sequence A funding earlier this 12 months.